Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 5Recruiting 4Completed 3Unknown 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 903Lung Neoplasms 490Small Cell Lung Carcinoma 140Neoplasms 111Melanoma 107Neoplasm Metastasis 105Breast Neoplasms 99Colorectal Neoplasms 94Ovarian Neoplasms 76Carcinoma, Renal Cell 64Pancreatic Neoplasms 62Squamous Cell Carcinoma of Head and Neck 58Mesothelioma 53Stomach Neoplasms 51Head and Neck Neoplasms 47Adenocarcinoma of Lung 46Triple Negative Breast Neoplasms 45Esophageal Neoplasms 40Colonic Neoplasms 40Brain Neoplasms 40Sarcoma 38Mesothelioma, Malignant 38Prostatic Neoplasms 37Urinary Bladder Neoplasms 36Recurrence 30Carcinoma, Transitional Cell 28Uterine Cervical Neoplasms 25Endometrial Neoplasms 25Carcinoma, Hepatocellular 21Carcinoma, Squamous Cell 19

Interventions

Radiotherapy 1Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Non Small Cell Lung Cancer Metastatic × Thoracic × Clear all
NCT03168464 2023-04-24

Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)

Weill Medical College of Cornell University

Phase 1/2 Terminated
15 enrolled 9 charts
Thoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡